Alpa Laboratories Limited (NSE:ALPA)

Market Cap	2.05B
Revenue (ttm)	1.12B
Net Income (ttm)	195.03M
Shares Out	21.04M
EPS (ttm)	9.34
PE Ratio	10.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,789
Average Volume	18,034
Open	98.55
Previous Close	97.49
Day's Range	93.55 - 98.56
52-Week Range	90.30 - 144.50
Beta	0.64
RSI	38.95
Earnings Date	Aug 12, 2025

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter pharmaceutical products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, creams, gels, and ointments for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and col...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Employees: 410
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALPA

Financial Performance

In 2024, Alpa Laboratories's revenue was 1.12 billion, an increase of 3.41% compared to the previous year's 1.09 billion. Earnings were 195.03 million, an increase of 16.25%.